Data, disease and diplomacy: GISAID's innovative contribution to global health

Cited by (1,005)

Items 301–400 of 1,005

1. The interplay of SARS-CoV-2 evolution and constraints imposed by the structure and functionality of its proteins
   Lukasz Jaroszewski, Mallika Iyer, Arghavan Alisoltani, Mayya Sedova, Adam Godzik · 2021 · PLoS Computational Biology
2. Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study
   Helene Kildegaard, Lars Christian Lund, Mikkel Højlund, Lone Graff Stensballe, Anton Pottegård · 2022 · BMJ
3. Taxonomical and functional changes in COVID ‐19 faecal microbiome could be related to SARS‐CoV ‐2 faecal load
   Lucia Grenga, Olivier Pible, Guylaine Miotello, Karen Culotta, Sylvie Ruat, Marie‐Anne Roncato, Fabienne Gas, Laurent Bellanger, Pierre‐Géraud Claret, Catherine Dunyach‐Remy et al. · 2022 · Environmental Microbiology
4. ViruSurf: an integrated database to investigate viral sequences
   Arif Canakoglu, Pietro Pinoli, Anna Bernasconi, Tommaso Alfonsi, Damianos P. Melidis, Stefano Ceri · 2020 · Nucleic Acids Research
5. SARS-CoV-2 Omicron Variant: ACE2 Binding, Cryo-EM Structure of Spike Protein-ACE2 Complex and Antibody Evasion
   Dhiraj Mannar, James W. Saville, Xing Quan Zhu, Shanti Swaroop Srivastava, Alison Berezuk, Katharine S. Tuttle, Citlali Marquez, Inna Sekirov, Sriram Subramaniam · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
6. Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets
   Ge Liu, Brandon Carter, David Kenneth Gifford · 2020 · Cell Systems
7. Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir
   Ross Martin, Jiani Li, Aiyappa Parvangada, Jason K. Perry, Tomáš Cihlář, Hongmei Mo, Danielle Porter, Evguenia S. Svarovskaia · 2021 · Antiviral Research
8. COVID-19, the first pandemic in the post-genomic era
   Lucy van Dorp, Charlotte J. Houldcroft, Damien Richard, François Balloux · 2021 · Current Opinion in Virology
9. Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context
   Vincenzo Tragni, Francesca Preziusi, Luna Laera, Angelo Onofrio, Ivan Mercurio, Simona Todisco, Mariateresa Volpicella, Anna Grassi, Ciro Leonardo Pierri · 2022 · The EPMA Journal
10. The twin-beginnings of COVID-19 in Asia and Europe—one prevails quickly
    Yongsen Ruan, Haijun Wen, Mei Hou, Ziwen He, Xuemei Lu, Yongbiao Xue, Xionglei He, Ya‐Ping Zhang, Chung‐I Wu · 2021 · National Science Review
11. Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
    Manojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, Sang‐Soo Lee, Chiranjib Chakraborty · 2022 · Folia Microbiologica
12. SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children
    Brian W. McCrindle, Ashraf S. Harahsheh, Ryan Handoko, Geetha Raghuveer, Michael A. Portman, Michael Khoury, Jane W. Newburger, Simon Lee, Supriya Jain, Manaswitha Khare et al. · 2023 · New England Journal of Medicine
13. Sinapic Acid Suppresses SARS CoV-2 Replication by Targeting Its Envelope Protein
    Raha Saud Orfali, Mostafa Ezzat Rateb, Hossam M. Hassan, Mona Awad Alonazi, Mokhtar R. Gomaa, Noura Mahrous, Mohamed GabAllah, Ahmed Kandeil, Shagufta Perveen, Usama Ramadan Abdelmohsen et al. · 2021 · Antibiotics
14. SARS‐CoV‐2 virulence evolution: Avirulence theory, immunity and trade‐offs
    Samuel Alizon, Mircea T. Sofonea · 2021 · Journal of Evolutionary Biology
15. Omicron: Call for updated vaccines
    Xingguang Li · 2021 · Journal of Medical Virology
16. Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus‐2 Omicron Variant of Concern
    S. K. Saxena, Swatantra Kumar, Saniya M. Ansari, J. Pawęska, Vimal K. Maurya, A. Tripathi, A. Abdel-Moneim · 2022 · Journal of Medical Virology
17. Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA
    Mindy M. Cheng, Carolina M. Reyes, Sacha Satram, Helen J. Birch, Daniel C. Gibbons, Myriam Drysdale, Christopher F. Bell, Anvar Suyundikov, Xiao Xia Ding, M. Cyrus Maher et al. · 2023 · Infectious Diseases and Therapy
18. Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
    Alejandro Llanes, Carlos Mario Restrepo, Zuleima Caballero E., Sreekumari Rajeev, Melissa A. Kennedy, Ricardo Lleonart · 2020 · International Journal of Molecular Sciences
19. Computational search for potential COVID-19 drugs from FDA-approved drugs and small molecules of natural origin identifies several anti-virals and plant products
    Abhishek Sharma, Vikas Ramyagya Tiwari, Ramanathan Sowdhamini · 2020 · Journal of Biosciences
20. Evolution of the SARS‐CoV ‐2 proteome in three dimensions (3D) during the first 6 months of the COVID ‐19 pandemic
    Joseph H. Lubin, Christine Zardecki, Elliott M. Dolan, Changpeng Lu, Zhuofan Shen, Shuchismita Dutta, John Westbrook, Brian P. Hudson, David S. Goodsell, Jonathan K. Williams et al. · 2021 · Proteins Structure Function and Bioinformatics
21. Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation
    David P. Maison, Lauren Lei Ching, Cecilia M. Shikuma, Vivek R. Nerurkar · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
22. Large-scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management
    Andrew J. Page, Alison E. Mather, Thanh Le-Viet, Emma J. Meader, Nabil-Fareed Alikhan, Gemma L. Kay, Leonardo de Oliveira Martins, Alp Aydin, David Baker, Alexander J. Trotter et al. · 2021 · Microbial Genomics
23. A biophysical model of viral escape from polyclonal antibodies
    Timothy C. Yu, Zorian Thornton, William W. Hannon, William S. DeWitt, Caelan E. Radford, Frederick A. Matsen IV, Jesse D. Bloom · 2022 · Virus Evolution
24. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
    Kāmini Walia, Marc Mendelson, Gagandeep Kang, Venkatasubramanian Ramasubramanian, Rina Sinha, Sonam Vijay, Balaji Veeraraghavan, Buddha Basnyat, Camilla S Rodrigues, Nitin Bansal et al. · 2023 · The Lancet Infectious Diseases
25. Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease
    Thomas J. Cross, Gemma R. Takahashi, Elizabeth M. Diessner, Marquise G. Crosby, Vesta Farahmand, Shannon Zhuang, Carter T. Butts, Rachel W. Martin · 2020 · Biochemistry
26. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands
    G Bezzi, Ernesto J. Piga, Andrés Binolfi, Pablo Armas · 2021 · International Journal of Molecular Sciences
27. Early computational detection of potential high-risk SARS-CoV-2 variants
    2023
28. SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission
    Nicolae Sapoval, Medhat Mahmoud, Michael D. Jochum, Yunxi Liu, Ryan A. Leo Elworth, Qi Wang, Dreycey Albin, Huw A. Ogilvie, Michael Lee, Sonia Villapol et al. · 2021 · Genome Research
29. Evolutionary and structural analysis of SARS-CoV-2 specific evasion of host immunity
    Irfan Hussain, Nashaiman Pervaiz, Abbas Khan, Shoaib Saleem, Huma Shireen, Dong‐Qing Wei, Viviane Labrie, Yīmíng Bào, Amir Ali Abbasi · 2020 · Genes and Immunity
30. Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain
    Zachariah P. Schuurs, Edward Hammond, Stefano Elli, Timothy Robert Rudd, Courtney J. Mycroft‐West, Marcelo Andrade de Lima, Mark Andrew Skidmore, Richard Torbjörn Gustav Karlsson, Yen‐Hsi Chen, Ieva Bagdonaite et al. · 2021 · Computational and Structural Biotechnology Journal
31. Detection of SARS-CoV-2 B.1.351 (Beta) Variant through Wastewater Surveillance before Case Detection in a Community, Oregon, USA
    Melissa Sutton, Tyler S. Radniecki, Devrim Kaya, Dana Alegre, Matthew J. Geniza, Anne-Marie Girard, Katherine Carter, Mark Dasenko, Justin L. Sanders, Paul R. Cieslak et al. · 2022 · Emerging infectious diseases
32. Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS‐CoV‐2 outbreak
    Denis C. Bauer, Aidan P. Tay, Laurence O. W. Wilson, Daniel Reti, Cameron Hosking, Alexander J. McAuley, Elizabeth A. Pharo, Shawn Todd, Vicky Stevens, Matthew J. Neave et al. · 2020 · Transboundary and Emerging Diseases
33. Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria
    Egon Anderson Ozer, Lacy M. Simons, Moses Olubusuyi Adewumi, Adeola Fowotade, Ewean Chukwuma Omoruyi, Johnson Adekunle Adeniji, Oluseyi Adebowale Olayinka, Taylor J. Dean, Janet P. Zayas, Pavan P. Bhimalli et al. · 2022 · Nature Communications
34. HAVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences
    Phuoc Truong Nguyen, Ilya Plyusnin, Tarja A. Sironen, Olli Vapalahti, Ravi Kant, Teemu Smura · 2021 · BMC Bioinformatics
35. Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report
    Jason D. Goldman, Kai Wang, Katharina Röltgen, Sandra C. A. Nielsen, Jared C. Roach, Samia N. Naccache, Fan Yang, Oliver Fabian Wirz, Kathryn E. Yost, Ji-Yeun Lee et al. · 2022 · Vaccines
36. Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread
    Gage K. Moreno, Katarina M. Braun, Kasen K. Riemersma, Michael A. Martin, Peter Halfmann, Chelsea M. Crooks, Trent M. Prall, David Baker, John James Baczenas, Anna S. Heffron et al. · 2020 · Nature Communications
37. poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing
    Christian Brandt, Sebastian Krautwurst, Riccardo Spott, Mara Lohde, Mateusz Jundzill, Mike Marquet, Martin Hölzer · 2021 · Frontiers in Genetics
38. Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients
    Xiuyuan Lu, Yuki Hosono, Masamichi Nagae, Shigenari Ishizuka, Eri Ishikawa, Daisuke Motooka, Yuki Ozaki, Nicolas Sax, Yuichi Maeda, Yasuhiro Kato et al. · 2021 · The Journal of Experimental Medicine
39. Effects of vaccination and non-pharmaceutical interventions and their lag times on the COVID-19 pandemic: Comparison of eight countries
    Hao Li, Luqi Wang, Mengxi Zhang, Yihan Lu, Weibing Wang · 2022 · PLoS neglected tropical diseases
40. Questioning the seasonality of SARS-COV-2: a Fourier spectral analysis
    Riccardo Cappi, Luca Casini, Davide Tosi, Marco Roccetti · 2022 · BMJ Open
41. SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event
    Madlen Stange, Alfredo Mari, Tim C. Roloff, Helena M. B. Seth-Smith, Michael Schweitzer, Myrta Brunner, Karoline Leuzinger, Kirstine K. Søgaard, Alexander Gensch, Sarah Tschudin‐Sutter et al. · 2021 · PLoS Pathogens
42. Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting
    Kaitlin Sawatzki, Nichola J. Hill, Wendy Blay Puryear, Alexa D. Foss, Jonathon J. Stone, Jonathan A. Runstadler · 2021 · Proceedings of the National Academy of Sciences
43. Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
    Aditya Kumar Padhi, Timir Tripathi · 2022 · Biochemical and Biophysical Research Communications
44. Evolutionary analysis of Omicron variant BF.7 and BA.5.2 pandemic in China
    Yamin Sun, Min Wang, Wenchao Lin, Wei Dong, Jianguo Xu · 2023 · Journal of Biosafety and Biosecurity
45. Perspective on Proteomics for Virus Detection in Clinical Samples
    Marica Grossegesse, Felix Hartkopf, Andreas Nitsche, Lars Schaade, Joerg Doellinger, Thilo Muth · 2020 · Journal of Proteome Research
46. Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore–Washington metropolitan area
    Peter Thielen, Shirlee Wohl, Thomas S. Mehoke, Srividya Ramakrishnan, Melanie Kirsche, Oluwaseun O Falade-Nwulia, Nídia S. Trovão, Amanda W. Ernlund, Craig Howser, Norah Sadowski et al. · 2021 · JCI Insight
47. Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland
    Chaoran Chen, Sarah Nadeau, Ivan Topolsky, Marc Manceau, Jana S. Huisman, Kim Philipp Jablonski, Lara Fuhrmann, David Dreifuss, Katharina Jahn, Christiane Beckmann et al. · 2021 · Epidemics
48. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors
    Daichao Wu, Alexander V. Kolesnikov, Rui Ming Yin, Johnathan D. Guest, Ragul Gowthaman, Anton Shmelev, Yana V. Serdyuk, Dmitry Vladimirovich Dianov, Grigory Aleksandrovich Efimov, Brian G. Pierce et al. · 2022 · Nature Communications
49. Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests
    Mary A. Rodgers, Ana Olivo, Barbara J Harris, Chris Lark, Xinxin Luo, Michael G. Berg, Todd V. Meyer, Aurash Mohaimani, Gregory S. Orf, Doctor Yitzchak Goldstein et al. · 2022 · Journal of Clinical Virology
50. Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates
    Barbara Schrörs, Pablo Riesgo-Ferreiro, Patrick Sorn, Ranganath Gudimella, Thomas Bukur, Thomas Rösler, Martin Löwer, Uğur Şahin · 2021 · PLoS ONE
51. Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020–2022
    Alexandre Rodrigues Marra, Vanderson de Souza Sampaio, Mina Cintho Ozahata, Rafael Lopes, Anderson Fernandes Brito, Marcelo Alves de Souza Bragatte, Jorge Elias Kalil, João Luiz Miraglia, Daniel Tavares Malheiro, Yang Guozhang et al. · 2023 · Infection Control and Hospital Epidemiology
52. A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection
    Martin A.M. Reijns, Louise Thompson, Juan Carlos Acosta, Holly A. Black, Francisco Jose Sanchez-Luque, Austin G. Diamond, David A. Parry, Alison Daniels, Marie F. O’Shea, Carolina Uggenti et al. · 2020 · PLoS Biology
53. Impact of low vaccine coverage on the resurgence of COVID-19 in Central and Eastern Europe
    Guihong Fan, Haitao Song, Stan Yip, Tonghua Zhang A, Daihai He · 2022 · One Health
54. Should RT‐PCR be considered a gold standard in the diagnosis of COVID‐19?
    María Teresa Hernández‐Huerta, Laura Perez-Campos Mayoral, Luis Manuel Sánchez Navarro, Gabriel Mayoral Andrade, Eduardo Pérez‐Campos Mayoral, Edgar Zenteno, Eduardo Pérez‐Campos · 2020 · Journal of Medical Virology
55. Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco
    Peng, James, Liu, Jamin, Mann, Sabrina A, Mitchell, Anthea M, Laurie, Matthew T, Sunshine, Sara, Pilarowski, Genay, Ayscue, Patrick, Kistler, Amy, Vanaerschot, Manu et al. · 2022 · Clinical Infectious Diseases
56. Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein
    Yue Xing, Xiao Li, Xiang Gao, Qunfeng Dong · 2020 · Frontiers in Genetics
57. Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics
    Hani A. Alhadrami, Ahmed M. Sayed, Hossam M. Hassan, Khayrya A. Youssif, Yasser Gaber, Yassmin Moatasim, Omnia Kutkat, Ahmed Mostafa, Mohamed A. Ali, Mostafa Ezzat Rateb et al. · 2021 · Antibiotics
58. The past, current and future epidemiological dynamic of SARS-CoV-2
    François Balloux, Cedric C.S. Tan, Leo Swadling, Damien Richard, Charlotte Jenner, Mala K. Maini, Lucy van Dorp · 2022 · Oxford Open Immunology
59. Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
    João M. Trigueiro-Louro, Vanessa Correia, Inês Figueiredo-Nunes, Marta Gíria, Helena Rebelo‐de‐Andrade · 2020 · Computational and Structural Biotechnology Journal
60. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)
    Osman Mutluhan Uğurel, Ozal Mutlu, Emrah Sarıyer, Sinem Koçer, Erennur Ugurel, T. Inci, Oğuz Ata, D. Turgut-Balik · 2020 · International Journal of Biological Macromolecules
61. Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective
    Cecilia Pozzi, Anne Vanet, Valeria Francesconi, Lorenzo Tagliazucchi, Giusy Tassone, Alberto Venturelli, Francesca Spyrakis, Marco Mazzorana, Maria Paola Costi, Michele Tonelli · 2023 · Journal of Medicinal Chemistry
62. SARS-CoV-2 variants: biology, pathogenicity, immunity and control
    Ryuta Uraki, Bette Korber, Michael Diamond, Yoshihiro Kawaoka · 2025 · Nature Reviews Microbiology
63. Evolution and rapid spread of a reassortant A(H3N2) virus that predominated the 2017–2018 influenza season
    Barney I. Potter, Rebecca J Garten Kondor, James Hadfield, John Huddleston, John Barnes, Thomas Rowe, Lizheng Guo, Xiyan Xu, Richard A. Neher, Trevor Bedford et al. · 2019 · Virus Evolution
64. D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect
    Romina Oliva, Abdul Rajjak Shaikh, Andrea Petta, Anna Vangone, Luigi Cavallo · 2021 · Molecules
65. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay
    Ester López, Ebene R. Haycroft, Amy Adair, Francesca L. Mordant, Matthew T. O’Neill, Phillip Pymm, Samuel J. Redmond, Wen Shi Lee, Nicholas A. Gherardin, Adam K. Wheatley et al. · 2021 · JCI Insight
66. Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein
    Afsaneh Sadremomtaz, Zayana M. Al-Dahmani, Angel Jonathan Ruiz-Moreno, Alessandra Monti, Chao Wang, Taha Azad, John Cameron Bell, Nunzianna Doti, Marco Antonio Velasco-Velázquez, Debora de Jong et al. · 2021 · Journal of Medicinal Chemistry
67. COVID-19 rise in Bangladesh correlates with increasing detection of B.1.351 variant
    Senjuti Saha, Arif Mohammad Tanmoy, Yogesh Hooda, Afroza Akter Tanni, Sharmistha Goswami, Syed Muktadir Al Sium, Mohammad Saiful Islam Sajib, Roly Malaker, Shuborno Islam, Hafizur Rahman et al. · 2021 · BMJ Global Health
68. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants
    Qian Wang, Yicheng Guo, Anthony D. Bowen, Ian A. Mellis, Riccardo Valdez, Carmen Gherasim, Aubree L. Gordon, Lihong Liu, David D. Ho · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
69. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates
    Nitin Chitranshi, Vivek Gupta, Rashi Rajput, Angela Godinez, Kanishka Pushpitha, Ting Shen, Mehdi Mirzaei, Yuyi You, Devaraj K. Basavarajappa, Veer Gupta et al. · 2020 · Journal of Translational Medicine
70. The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789
    Alejandro Flores-Alanis, Luisa Sandner-Miranda, Gabriela Delgado, Alejandro Cravioto, Rosario Morales-Espinosa · 2020 · BMC Research Notes
71. SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021—Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing
    Ana Rita Goncalves Cabecinhas, Tim C. Roloff, Madlen Stange, Claire Bertelli, Michael Huber, Alban Ramette, Chaoran Chen, Sarah Nadeau, Yannick Gerth, Sabine Yerly et al. · 2021 · Microorganisms
72. Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity
    Yvan Butera, Enatha Mukantwari, Maria Artesi, Jeanne d’Arc Umuringa, Áine O’Toole, Verity Hill, Stefan Rooke, Samuel Leandro Hong, Simon Dellicour, Onesphore Majyambere et al. · 2021 · Nature Communications
73. A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
    Zhenlin Yang, Yulu Wang, Yujia Jin, Yuanfei Zhu, Yanling Wu, Cheng Li, Yu Kong, Wenping Song, Xiaolong Tian, Wuqiang Zhan et al. · 2021 · Signal Transduction and Targeted Therapy
74. Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
    Craig W. Fenwick, Priscilla Turelli, Dongchun Ni, Laurent H. Perez, Kelvin Lau, Cécile Hérate, Romain Marlin, Erica Lana, Céline Pellaton, Charlène Raclot et al. · 2022 · Nature Microbiology
75. A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020
    Broňa Brejová, Kristína Boršová, Viktória Hodorová, Viktória Čabanová, Lenka Reizigová, Evan David Paul, Pavol Čekan, Boris Klempa, Jozef Nosek, Tomáš Vinař · 2021 · Virus Genes
76. Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance
    Alfredo Mari, Tim C. Roloff, Madlen Stange, Kirstine K. Søgaard, Erblin Asllanaj, Gerardo Tauriello, Leila T. Alexander, Michael Schweitzer, Karoline Leuzinger, Alexander Gensch et al. · 2021 · Microorganisms
77. SARS-CoV-2 spike E156G/Δ157-158 mutations contribute to increased infectivity and immune escape
    Tarun Kumar Mishra, Rishikesh Dalavi, Garima Joshi, Atul Kumar, Pankaj Pandey, Sanjeev Shukla, Ram Kumar Mishra, Ajit G. Chande · 2022 · Life Science Alliance
78. Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein
    Zhen Wah Tan, Wei-Ven Tee, Firdaus Samsudin, Enrico Guarnera, Peter John Bond, Igor N. Berezovsky · 2022 · Structure
79. Genomic and transcriptomic characterization of delta SARS-CoV-2 infection in free-ranging white-tailed deer (Odocoileus virginianus)
    Jonathon D. Kotwa, Briallen Lobb, Ariane Massé, Marianne Gagnier, Patryk Aftanas, Arinjay Banerjee, Andra Banete, Juliette Blais-Savoie, Jeff Bowman, Tore Buchanan et al. · 2023 · iScience
80. Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function
    Darren Patrick Martin, Spyros Lytras, Alexander G. Lucaci, Wolfgang Maier, Björn Andreas Grüning, Stephen D. Shank, Steven Weaver, Oscar A. MacLean, Richard J Orton, Philippe Lemey et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
81. Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements
    Michelle F. Rourke · 2019 · Milbank Quarterly
82. Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations
    Brittany A. Petros, Jacquelyn Turcinovic, Nicole L. Welch, Laura Forsberg White, Eric D. Kolaczyk, Matthew R. Bauer, Michael Cleary, Sabrina T. Dobbins, Lynn Doucette‐Stamm, Mitch Gore et al. · 2022 · Clinical Infectious Diseases
83. Prophylactic and therapeutic vaccine development: advancements and challenges
    Induni Nayodhara Weerarathna, Elijah Skarlus Doelakeh, Lydia Kiwanuka, Praveen Kumar, Sanvi Arora · 2024 · Molecular Biomedicine
84. Evolutionary artificial intelligence based peptide discoveries for effective Covid-19 therapeutics
    Ritika Kabra, Shailza Singh · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
85. Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target
    Alina Renz, Lina Widerspick, Andreas Dräger · 2021 · Genes
86. Variant-driven early warning via unsupervised machine learning analysis of spike protein mutations for COVID-19
    Adele de Hoffer, Shahram Vatani, Corentin Cot, Giacomo Cacciapaglia, Maria Luisa Chiusano, Andrea Cimarelli, F. Conventi, Antonio Giannini, Stefan Hohenegger, Francesco Sannino A · 2022 · Scientific Reports
87. Loop-Mediated Isothermal Amplification: From Theory to Practice
    Fedor V. Shirshikov, Julia Bespyatykh · 2022 · Russian Journal of Bioorganic Chemistry
88. Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria
    Ozer, Egon A., Simons, Lacy M., Adewumi, Olubusuyi M., Fowotade, Adeola A., Omoruyi, Ewean C., Adeniji, Johnson A., Dean, Taylor J., Zayas, Janet, Bhimalli, Pavan P., Ash, Michelle K. et al. · 2021
89. The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City
    Alberto Cedro‐Tanda, Laura Gómez-Romero, Nicolás Alcaraz, Guillermo de Anda‐Jáuregui, Fernando Peñaloza, Bernardo Moreno, Marco A. Escobar-Arrazola, Oscar A. Ramirez-Vega, Paulina Munguía-Garza, Francisco Garcia-Cardenas et al. · 2021 · Viruses
90. Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis
    Surendra S. Negi, Catherine H. Schein, Werner A. Braun · 2022 · Scientific Reports
91. A rapid, low-cost, and highly sensitive SARS-CoV-2 diagnostic based on whole-genome sequencing
    Per A. Adastra, Neva C. Durand, Namita Mitra, Saul Godinez Pulido, Ragini Mahajan, Alyssa Blackburn, Zane Colaric, Joshua W. M. Theisen, David Weisz, Olga Dudchenko et al. · 2023 · PLoS ONE
92. Mutation signatures inform the natural host of SARS-CoV-2
    Shanjun Deng, Ke Xing, Xionglei He · 2021 · National Science Review
93. Multi‐species outbreak of SARS‐CoV‐2 Delta variant in a zoological institution, with the detection in two new families of carnivores
    Matthew C. Allender, Michael J. Adkesson, Jennifer N. Langan, Katie W. Delk, Thomas Meehan, Copper Aitken‐Palmer, Michael S. McEntire, Mary Lea Killian, Mia Kim Torchetti, Shirley A. Morales et al. · 2022 · Transboundary and Emerging Diseases
94. Molecular adaptations during viral epidemics
    Nash D. Rochman, Yuri I. Wolf, Eugene V. Koonin · 2022 · EMBO Reports
95. SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade
    Firdaus Samsudin, Palur Venkata Raghuvamsi, Ganna Petruk, Manoj Puthia, Jitka Petrlová, Paul A. MacAry, Ganesh S. Anand, Peter John Bond, Artur Schmidtchen · 2022 · Journal of Molecular Cell Biology
96. City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants
    Franziska S. Brunner, Mathew Robert Brown, Irene Bassano, Hubert Denise, Mohammad S. Khalifa, Matthew J. Wade, Ronny van Aerle, Jessica L. Kevill, Davey L. Jones, Kata Farkas et al. · 2022 · Water Research
97. Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic
    Luis Daniel González-Vázquez, Miguel Arenas · 2023 · Genes
98. Using big sequencing data to identify chronic SARS-Coronavirus-2 infections
    Sheri Harari, Danielle Miller, Shay Fleishon, David Burstein, Adi Stern · 2024 · Nature Communications
99. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein
    Shijian Zhang, Eden P. Go, Haitao Ding, Saumya Anang, John C. Kappes, Heather Desaire, Joseph Sodroski · 2021 · Journal of Virology
100. Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology
     Mauro Petrillo, Carlo Brogna, Simone Cristoni, Maddalena Querci, Ornella Piazza, Guy Van den Eede · 2021 · F1000Research